Your browser doesn't support javascript.
loading
Blood types (ABO/Rhesus) and SARS-CoV-2 infection: a retrospective, cross-sectional study in 2828 healthcare workers.
Copur, Betul; Surme, Serkan; Sayili, Ugurcan; Tuncer, Gulsah; Ozcelik, Melike Nur; Yilmaz-Ak, Hulya; Topal, Muge; Ustun-Al, Sumeyye; Pehlivanoglu, Filiz; Sengoz, Gonul.
Affiliation
  • Copur B; Department of Infectious Diseases & Clinical Microbiology, Haseki Training & Research Hospital, Istanbul, 34096, Turkey.
  • Surme S; Department of Infectious Diseases & Clinical Microbiology, Haseki Training & Research Hospital, Istanbul, 34096, Turkey.
  • Sayili U; Department of Medical Microbiology, Institute of Graduate Studies, Istanbul University-Cerrahpasa, Istanbul, 34098, Turkey.
  • Tuncer G; Department of Public Health, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, 34098, Turkey.
  • Ozcelik MN; Department of Infectious Diseases & Clinical Microbiology, Haseki Training & Research Hospital, Istanbul, 34096, Turkey.
  • Yilmaz-Ak H; Department of Infectious Diseases & Clinical Microbiology, Haseki Training & Research Hospital, Istanbul, 34096, Turkey.
  • Topal M; Department of Anesthesiology & Reanimation, Lutfi Kirdar Kartal Training & Research Hospital, Istanbul, 34865, Turkey.
  • Ustun-Al S; Infection Control Committee, Haseki Training & Research Hospital, Istanbul, 34096, Turkey.
  • Pehlivanoglu F; Infection Control Committee, Haseki Training & Research Hospital, Istanbul, 34096, Turkey.
  • Sengoz G; Department of Infectious Diseases & Clinical Microbiology, Haseki Training & Research Hospital, Istanbul, 34096, Turkey.
Future Virol ; 2022 Oct.
Article in En | MEDLINE | ID: mdl-36299278
ABSTRACT

Background:

The authors aimed to investigate the relationship between ABO/Rhesus blood types and the risk of SARS-CoV-2 infection and hospitalization in healthcare workers (HCWs). Materials &

methods:

This study compared HCWs with (n = 510) and without (n = 2318) SARS-CoV-2 infection. Risk factors for SARS-CoV-2 infection and hospitalization in HCWs were shown as odds ratios with 95% CI.

Results:

Blood group O was found to be protective by 20% from the risk of developing SARS-CoV-2 infection in HCWs (29.2 vs 33.8%; odds ratio 0.808; 95% CI 0.655-0.996; p = 0.045). The prevalence of group O was lower in hospitalized patients than in outpatients (25 vs 29.5%; p = 0.614).

Conclusion:

These findings suggest that blood groups are associated with the development of SARS-CoV-2 infection.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prevalence_studies / Risk_factors_studies Language: En Journal: Future Virol Year: 2022 Document type: Article Affiliation country: Turquía

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prevalence_studies / Risk_factors_studies Language: En Journal: Future Virol Year: 2022 Document type: Article Affiliation country: Turquía